Morphine Infusion Dosing for Sedation in Opioid-Naïve Adults
For opioid-naïve adults requiring sedation, start with an intravenous morphine bolus of 2 mg, followed by a continuous infusion starting at 2-10 mg/hour, titrated to effect with no specified dose limit. 1
Initial Bolus Dosing
- Administer 2 mg IV morphine as the starting bolus dose for symptomatic opioid-naïve adults requiring sedation 1
- The FDA-approved starting dose range is 0.1-0.2 mg/kg every 4 hours, but in practice, a fixed 2 mg bolus is the standard for sedation initiation 2
- Adjust the starting dose based on patient size, age, and organ dysfunction—elderly or frail patients may require lower initial doses 1
- For cancer pain management specifically, the initial IV dose is 2-5 mg for opioid-naïve patients 3
Continuous Infusion Initiation
- Start continuous infusion at 2-10 mg/hour after the initial bolus 4
- An alternative approach: calculate the infusion rate as 50% of the cumulative bolus dose required to achieve initial symptom control 5
- In end-of-life care for breathlessness, start with 10 mg over 24 hours (approximately 0.4 mg/hour) via subcutaneous infusion if needed frequently 6
Titration Strategy
- Administer bolus doses of 2 mg IV every 15 minutes as needed for breakthrough symptoms 1
- If the patient is already receiving an infusion and develops symptoms, give a bolus equal to two times the hourly infusion rate 1
- Double the infusion rate if the patient requires two bolus doses within one hour 1
- Titrate to symptoms with no specified maximum dose limit—the goal is symptom control, not arbitrary dose ceilings 1
Critical Monitoring Parameters
- Assess respiratory rate continuously—rates below 8 breaths/minute indicate severe respiratory depression requiring intervention 7
- Monitor for excessive sedation, which is the earliest sign of opioid overdose before respiratory depression develops 7, 8
- Evaluate pain and sedation using standardized scoring systems rather than relying solely on vital sign thresholds 1, 9
- Watch for chest wall rigidity with rapid IV administration, which can compromise ventilation 2
Special Populations Requiring Dose Reduction
- Elderly patients: reduce dose by 20% or more and use longer intervals between doses 10, 1
- Renal impairment (eGFR <30 mL/min): switch to oxycodone instead of morphine due to accumulation of active metabolites (morphine-6-glucuronide) 6, 3
- Hepatic impairment: start at lower doses and titrate cautiously due to altered metabolism 4, 2
Adjunctive Medications
- Always co-prescribe an antiemetic (such as haloperidol 0.5-2 mg IV every 4-6 hours) as nausea occurs in up to two-thirds of patients starting morphine 10, 6, 8
- Prescribe a stimulant laxative prophylactically (such as senna) as constipation is the most persistent opioid side effect 6, 11
- Consider benzodiazepines (midazolam 2 mg IV bolus followed by 1 mg/hour infusion) only after pain and dyspnea are controlled with opioids 1
Common Pitfalls to Avoid
- Do not use continuous morphine infusions for procedural sedation—fentanyl (50-100 µg initial dose, supplemental 25 µg every 2-5 minutes) is preferred due to faster onset (1-2 minutes) and shorter duration 10
- Avoid morphine in patients with renal failure without dose adjustment, as active metabolites accumulate and cause prolonged sedation and respiratory depression 3, 4
- Do not routinely combine continuous infusions with PCA boluses in postoperative patients—this increases total opioid consumption without improving analgesia 12
- Rapid IV push can cause chest wall rigidity and cardiovascular instability from sympathetic hyperactivity 2
Reversal Protocol
- Prepare naloxone 0.4 mg diluted to 10 mL (0.04 mg/mL concentration) 7, 8
- Administer 0.04-0.08 mg (1-2 mL) IV every 30-60 seconds until respiratory rate improves to >10 breaths/minute 7, 8
- The goal is to reverse respiratory depression without eliminating analgesia 7
- Naloxone half-life (30-45 minutes) is shorter than morphine, so repeated doses or continuous infusion may be required 10, 7